Specificity of temporal amygdala atrophy in alzheimer’s disease: Quantitative assessment with magnetic resonance imaging

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 1, 1996, Pages 10-14

  Maunoury, Christophe ^a,b   Michot, Jean Luc ^b   Calllet, Hubert ^a   Parlato, Vincenzo ^b   Leroy Willig, Anne ^a   Jehenson, Philippe ^a   Syrota, André ^a   Boller, François ^b  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b INSERM   (France)

Author keywords

Alzheimer s disease; MRI; Neuroimaging; Temporal amygdala

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN ATROPHY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYGDALA; ATROPHY; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PROSPECTIVE STUDIES; REFERENCE VALUES; TEMPORAL LOBE;

EID: 0030063050     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106846     Document Type: Article

References (21)

1. Brady DR, Mufson EJ: Amygdaloid palhology in Alzheimer's disease: Qualitative and quantitative analysis. Dementia 1990;1:5-17.
2. Herzog AG, Kemper TL: Amygdaloid changes in aging and dementia. Arch Neurol 1980:37: 625-629.
3. Scott SA, deKosky ST, SchefT SW: Volumetric atrophy of the amygdala in Alzheimer’s disease: Quantitative serial reconstruction. Neurology 1991;41:351-356.
4. Jack CR Jr, Petersen RC, O’Brien PC, Tangalos EG: MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 1992;42.183-188.
5. Kesslak JP, Nalcioglu O, Cotman CW: Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer’s disease. Neurology 1991;41:51- 54.
6. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F: Temporal lobe regions on magnetic resonance imaging identity patients with early Alzheimer’s disease. Arch Neurol 1993;50:949-954.
7. Rusinek H, deLeon MJ, George AE, Stylopou-los LA, Chandra R, Smith G, Rand T, Mourino M, Kowalski H: Alzheimer disease: Measuring loss of cerebral gray matter with MR imaging. Radiology 1991;178:109-114.
8. Seab JP, Jagust WJ, Wong STS, Roos MS, Reed BR, Budinger TF: Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988;8: 200-208.
9. McDonald RJ, White NM: A triple dissociation of memory systems: Hippocampus, amygdala, and dorsal striatum. Behav Neurosci 1993;107:3-22.
10. Trancl D, Hyman BT: Neuropsychological correlates of bilateral amygdala damage. Arch Neurol 1990;47:349-355.
11. Cuenod CA, Denys A, Michot JL, Jehenson P, Forette F, Kaplan D, Syrota A, Boiler F: Amygdala atrophy in Alzheimer's disease: An in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-945.
12. McKhann G, Drachman D, Folstein M, Katz-man R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the N1NCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984:34:939-944.
13. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, and participating CERAD neuropathologists: The consortium to establish a registry for Alzheimer's disease (CERAD), part II: Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 1991;41:479-486.
14. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C, and the CERAD investigators: The consortium to establish a registry for Alzheimer’s disease (CERAD), part I: Clinical and neuropsychological assessment of Alzeimer's disease. Neurology 1989;39:1159-1165.
15. Folstein MF, Folstein SE, McHugh PR: Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Bronen RA, Cheung G: Relationship of hippocampus and amygdala to coronal MRI landmarks. Man Reson Imaging 1991;9:449-457.
17. Naidich TP, Daniels DL, Haughton VM, Williams A, Pojunas K, Palacios E: Hippocampal formation and related structures of the limbic lobe; Anatomic-MR correlation. Radiology 1987;162:747-761.
18. Murphy DGM, DcCarli C, Schapiro MB, Ra-poport SI, Horwitz B: Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol 1992;49:839-845.
19. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR 1987;149:351-356.
20. Kozachuk WE, deCarli C, Schapiro MB, Wagner EE, Rapoport SI, Horwitz B: White matter hyperintensities in dementia of Alzheimer’s type and in healthy subjects without cerebrovascular risk factors. Arch Neurol 1990; 47:1306-1310.
21. Kumar A, Yousem D, Souder E, Miller D, Gottlieb G, Gur R, Alavi A: High-intensity signals in Alzheimer’s disease without cerebrovascular risk factors: A magnetic resonance imaging evaluation. Am J Psychiatry 1992:149: 248-250.